The Connecticut Attorney General is suing McKesson Corp [1]., the nation’s largest pharmaceutical distributor, on allegations it illegally inflated wholesale drug costs for many brand-name drugs, including Lipitor and Prevacid.
Genzyme Corp. spent $640,000 lobbying the federal government [2] in the first quarter on matters such as on patent-reform legislation and bills that would allow generic drug companies to sell cheaper copies of biotech drugs, according to a disclosure form.
Blogger J. Matthew Buchanan has opened the doors to his new firm, Buchanan Intellectual Property Office LLC (BIPO), along with a new website Effective IP [3].
The US Patent and Trademark Office has published what’s being dubbed as the iPhone Patent [4], a 371-page whopper that covers Apple’s handheld multi-touch UI paradigm in excruciating detail. Days until the arrival of the second coming [5]: 10.
Efficacy Brands has come out with chewable, cherry-flavored dextrose tablets, Obecalp (placebo spelled backward), which are being sold as a placebo for parents to give their kids [6]. This should go a long way in promoting a drug-free nation.
Ernst & Young’s 22nd annual Beyond Borders: Global Biotechnology Report [7] says we’re in for a period of mega-deals in the industry.
The ABA [8] has paired with Justia.com, a legal information portal, to create a search engine covering all of the 1,800-plus blogs in our directory — including Patent Baristas [9]. Blawg Search [10] is like Google for lawyers.